Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
Resource type
Journal Article
Authors/contributors
- Singh, Nina (Author)
- Winston, Drew J. (Author)
- Razonable, Raymund R. (Author)
- Lyon, G. Marshall (Author)
- Silveira, Fernanda P. (Author)
- Wagener, Marilyn M. (Author)
- Stevens-Ayers, Terry (Author)
- Edmison, Bradley (Author)
- Boeckh, Michael (Author)
- Limaye, Ajit P. (Author)
Title
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
Abstract
This randomized trial compares preemptive therapy vs antiviral prophylaxis with valganciclovir in cytomegalovirus (CMV)-seronegative liver transplant recipients with seropositive donors for the prevention of CMV disease.
Publication
JAMA
Date
2020-4-14
Volume
323
Issue
14
Pages
1378-1387
Journal Abbr
JAMA
Accessed
9/22/22, 9:30 AM
PMID
32286644
PMCID
PMC7157180
ISSN
0098-7484
Library Catalog
PubMed Central
Citation
Singh, N., Winston, D. J., Razonable, R. R., Lyon, G. M., Silveira, F. P., Wagener, M. M., Stevens-Ayers, T., Edmison, B., Boeckh, M., & Limaye, A. P. (2020). Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors. JAMA, 323(14), 1378–1387. https://doi.org/10.1001/jama.2020.3138
ORGANISMS
ATC 2023 Top Papers in TID
Link to this record